Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01844999 · ClinicalTrials.gov registry record · NA

Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks

A NA study of Prostate Cancer, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
392
Enrollment target
4
Study locations

NCT01844999 is a NA study of Prostate Cancer that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 392 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (36% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01844999, a NA study of Prostate Cancer, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
392 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to determine whether using the P3P website can increase decisional preparation and satisfaction, and decrease decisional conflict, in men deciding how to manage early stage prostate cancer.

Conditions Studied

Prostate Cancer

Interventions

  • BEHAVIORAL Personal Patient Profile - Prostate (P3P)
  • BEHAVIORAL Standard prostate cancer information websites

Study Locations (4)

California

  • Kaiser Permanente - Souther California - Downey
  • Kaiser Permanente - Southern California - Los Angeles

Georgia

  • Emory Healthcare - Atlanta

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 392 participants
Start Date 2013-08-01
Est. Completion 2017-06-30
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01844999

The ClinicalTrials.gov registry entry for NCT01844999 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 392 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (36% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Personal Patient Profile - Prostate (P3P) is the first listed.

NCT01844999 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, Georgia, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01844999 about?

NCT01844999 is a clinical study titled "Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks". The purpose of this study is to determine whether using the P3P website can increase decisional preparation and satisfaction, and decrease decisional conflict, in men deciding how to manage early stage prostate cancer.

What is the current status of trial NCT01844999?

This trial is currently completed. It is a NA study. The enrollment target is 392 participants. The study started on 2013-08-01. Estimated completion is 2017-06-30.

What conditions does trial NCT01844999 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT01844999?

The interventions under investigation include: Personal Patient Profile - Prostate (P3P) (BEHAVIORAL), Standard prostate cancer information websites (BEHAVIORAL).

Who is sponsoring clinical trial NCT01844999?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01844999 being conducted?

This trial has 4 study locations across California, Georgia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.